Tag: checkpoint therapeutics

March 13, 2019

Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101

Checkpoint Therapeutics (NASDAQ:CKPT) has announced that the European Patent Office (EPO) has issued a composition of matter patent for the...
January 13, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Up During JPM Week

Axsome Therapeutics, Checkpoint Therapeutics, Bellerophon Therapeutics, Enochian Bioscience and Equillium were last week's top gainers.
November 2, 2018

Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results

Checkpoint Therapeutics (NASDAQ:CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients...
September 6, 2018

Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101

Checkpoint Therapeutics (NASDAQ:CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients...